Psirenity appoints new CEO and COO to accelerate delivery of mental health and wellness treatments TORONTO, July 06, 2021 (GLOBE NEWSWIRE) -- Psirenity Chairman Chris McCullough today announced the appointment of Mark Thompson to Chief Executive Officer and Wayne Kreppner to Chief Operating...

New Leaf Canada Gets Health Canada Approval for Psirenity to Begin Building Psilocybin Research Facility in Norfolk County TORONTO, April 21, 2021 (GLOBE NEWSWIRE) -- New Leaf Canada Inc. today announced it has received approval from Health Canada that will allow its wholly owned subsidiary Psirenity to begin...

Psirenity signs partnership with Jamaica’s Scientific Research Council to conduct joint studies into beneficial effects of psilocybin mushrooms TORONTO, April 01, 2021 (GLOBE NEWSWIRE) -- Psirenity, a wholly owned subsidiary of New Leaf Canada Inc., today announced it has signed a two-year partnership with Jamaica’s Scientific Research...

Psirenity granted approval to conduct Jamaica’s first psilocybin clinical trial to help manage depression TORONTO, March 29, 2021 (GLOBE NEWSWIRE) -- Psirenity, a wholly owned subsidiary of New Leaf Canada Inc., today announced it has received approval to conduct the first clinical trial protocol with...